Literature DB >> 1656744

Nosocomial outbreaks: the Centers for Disease Control's Hospital Infections Program experience, 1980-1990. Epidemiology Branch, Hospital Infections Program.

W R Jarvis1.   

Abstract

From January 1980 to July 1990, the Hospital Infections Program of the Centers for Disease Control conducted 125 on-site epidemiologic investigations of nosocomial outbreaks. Seventy-seven (62%) were caused by bacterial pathogens, 11 (9%) were caused by fungi, 10 (8%) were caused by viruses, five (4%) were caused by mycobacteria, and 22 (18%) were caused by toxins or other organisms. The majority of fungi and mycobacterial outbreaks occurred since July 1985. Fourteen (11%) outbreaks were device related, 16 (13%) were procedure related, and 28 (22%) were product related. The proportion of outbreaks involving products, procedures, or devices increased from 47% during 1980-1985 to 67% between 1986 and July 1990. Recent outbreaks have shown that packed red blood cell transfusion-associated Yersinia enterocolitica sepsis results from contamination of the blood by the asymptomatic donor; that povidone-iodine solutions can become intrinsically contaminated and cause outbreaks of infection and/or pseudoinfection; and that rapidly growing mycobacteria can cause chronic otitis media, surgical wound infection, and hemodialysis-associated infections. These and other outbreaks demonstrate how epidemiologic and laboratory investigations can be combined to identify new pathogens and sources of infection and ultimately result in disease prevention.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656744     DOI: 10.1016/0002-9343(91)90352-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Outbreaks associated with contaminated antiseptics and disinfectants.

Authors:  David J Weber; William A Rutala; Emily E Sickbert-Bennett
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

Review 2.  Radiation and ethylene oxide terminal sterilization experiences with drug eluting stent products.

Authors:  Byron J Lambert; Todd A Mendelson; Michael D Craven
Journal:  AAPS PharmSciTech       Date:  2011-09-02       Impact factor: 3.246

Review 3.  Pathogenesis of infections related to intravascular catheterization.

Authors:  D A Goldmann; G B Pier
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

4.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

Review 5.  Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.